NICE recommends new injectable immunotherapy treatment for rare triple negative breast cancer
The National Institute for Health and Care Excellence (NICE) has recommended pembrolizumab in combination with chemotherapy (paclitaxel or nab-paclitaxel) (Injectable immunotherapy treatment) which is...